Return on Tangible Equity: The amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity. Calculated as: Income from Continuing Operations / Tangible Shareholders Equity
Medicus Pharma Ltd (MDCX) had Return on Tangible Equity of -190.11% for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
$-6.18M |
|
-- |
|
-- |
|
$6.02M |
|
$-6.02M |
|
$-0.16M |
|
$-6.18M |
|
$-6.18M |
|
$-6.18M |
|
$-6.18M |
|
$-6.18M |
|
$-6.18M |
|
$-6.02M |
|
$-6.02M |
|
14.28M |
|
14.28M |
|
$-0.43 |
|
$-0.43 |
|
| Balance Sheet Financials | |
$11.00M |
|
-- |
|
$0.94M |
|
$11.93M |
|
$8.54M |
|
-- |
|
$0.14M |
|
$8.69M |
|
$3.25M |
|
$3.25M |
|
$3.25M |
|
15.94M |
|
| Cash Flow Statement Financials | |
$-9.41M |
|
-- |
|
$14.92M |
|
$4.16M |
|
$9.67M |
|
$5.51M |
|
$0.23M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.29 |
|
-- |
|
-- |
|
-- |
|
1.45 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-9.41M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-190.11% |
|
|
Return on Tangible Equity |
-190.11% |
-51.75% |
|
-190.11% |
|
$0.20 |
|
$-0.66 |
|
$-0.66 |
|